Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Conversion of IV Mircera in Hemodialysis Patients
NCT00048035Phase 2Completed
- Sponsor
- Roche
- Start
- Mar 2002
- Primary completion
- Jun 2005
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Started Mar 2002; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00048035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048035.